The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.DN-d7ZPu.js ...
With a focus on healthy living and information on advances in breast cancer treatment, Mayo Clinic is holding an educational ...
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 ...
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...
Discover the debate surrounding the labeling of DCIS as a cancer diagnosis and its impact on patient treatment and research ...
A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...
French lawmakers have voted unanimously to ensure breast cancer patients no longer have to pay out of pocket for the ...
Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...
Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...